 |
N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine disulphate salt |
|---|---|
| Trade Name | |
| Orphan Indication | Progressive supranuclear palsy |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-20 00:00:00 |
| Sponsor | Alzprotect sas;70 rue du docteur Alexandre Yersin;Loos |
